Covid-19 and thrombosis: what do we know about the risks and treatment?

This BMJ news report discusses the observed increased risk of thrombosis in patients with Covid-19. One expert notes that there are still high rates of DVT, PE and immunothrombosis in Covid-19 patients despite prophylaxis, with some arguing that bigger doses should be given.

SPS commentary:

Although NHS England has commissioned clinical guidance on thrombosis and critical care for patients with Covid-19, it has not yet been published. When available it is likely to be limited, as there has been so little research in this area. An expert notes that another question that needs answering urgently is whether patients with Covid-19 who are discharged should receive anticoagulants, and if so for how long.


British Medical Journal